Tarsus Pharmaceuticals
在场
高管
查看带有其 30 名主要高管的组织结构图
Tarsus Pharmaceuticals 搜索最多的简介
- Bobak Azamian, Chief Executive Officer and Chairman of the Board
- Andrew Goldberg, Director
- William Link, Director
高管在Tarsus Pharmaceuticals变化
- Kate Goodrich已作为Director加入公司 (新闻发布的2024十一月14号).
- Elizabeth Yeu 曾任 Director, 现升职为 Chief Medical Officer and Director (新闻发布的2024十一月6号).
创建提醒
跟踪 Tarsus Pharmaceuticals 的高管变动
药店
Tarsus Pharmaceuticals 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Tarsus Pharmaceuticals 的最新新闻稿
- News Releases | Tarsus Pharmaceuticals
- News Releases | Tarsus Pharmaceuticals
- Tarsus to Present at the Jefferies 2022 Healthcare Conference | Tarsus Pharmaceuticals
- Tarsus Reports First Quarter 2022 Financial Results and Recent Business Achievements | Tarsus Pharmaceuticals
- Tarsus to Present at Bank of America 2022 Healthcare Conference | Tarsus Pharmaceuticals
- Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting | Tarsus Pharmaceuticals
- News Releases | Tarsus Pharmaceuticals
- Tarsus Announces Pricing of Upsized $75.6 Million Underwritten Public Offering of Common Stock | Tarsus Pharmaceuticals
- News Releases | Tarsus Pharmaceuticals
- Tarsus Announces Positive Topline Data from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis, and Expects to File a New Drug Application This Year | Tarsus Pharmaceuticals
- View more press releases Close
通过电子邮件
